B A C K G R O U N D Description of the condition
Critical Illness includes any condition that results in a stay in a critical care (CCU), intensive care (ICU), or high dependency unit (HDU) within a hospital, whether due to surgical complication, injury, trauma, exacerbated chronic illness, or acute onset of severe illness. It is often the case that critical care patients exhibit multiple pathologies and have a high risk of other comorbities, including increased risk of a cardiac episode, respiratory weakness, and development of diabetes. The episode of critical illness is not limited to the period in intensive care but can continue to influence the patients' and their families' lives for months and often years after hospital discharge (Angus 1997; Chaboyer 2003; Eddleston 2000; Elliott 2006; Fletcher 2003; Frank 2000) . The traditional goal of intensive and critical care medicine has been to decrease short-term mortality (Angus 2003) . In recent years, both technological and medical advancements have resulted in more and more patients surviving intensive care (King 1998; Lewis 2003) , leading to a need for greater patient turnover as ward beds need to be vacated for new admittances. Consequently, hospital discharge often occurs earlier, with a less prolonged implementation period to re-develop each patient's physical and psychological status. Critical illness has a large weighting across the UK, and globally, with a prolonged stay in ICU associated with high mortality, morbidity, and costs (Martin 2005) . The critical care population are a unique population in many ways, despite their heterogeneity (varied reasons for admission, large age range and background). As other ill populations look to maintain health or hinder the progression of the disease, many of those surviving intensive care have the opportunity to not simply maintain but improve and develop their strength, fitness, physical function, and quality of life. Many factors can influence the individual experiences of ICU, irrespective of the admitting condition, but similar results are often observed by clinicians and researchers as survivors can suffer reduced physical function and independence, muscular atrophy and weakness, malnutrition and anaemia, and critical illness polyneuropathy and myopathy, all of which may negatively affect their quality of life. The majority of these contributing factors are associated with the admitting cause and the necessary treatment pathway prescribed by the medical staff, which cannot be greatly altered. It is, therefore, important to focus on prolonged and effective recovery and rehabilitation.
Description of the intervention
Regular exercise (physical activity) is known to improve the working function of many systems within the body, as well as to benefit muscular strength and size, improve balance and fitness, reduce the fear of falling in the elderly, and reduce the associated risk of hospital admission or re-admission. This has also been highlighted in other ill populations (reviewed by Kouidi 2002 for renal disease; Lavie 2009 for heart disease; and Puhan 2006 for pulmonary disease).
How the intervention might work
Older adults who regularly participate in physical training often gain significant improvements in both strength and aerobic power ( Grimby 1986). Previously 'frail' older adults have greatly increased their functional ability (Gill 2002) , helping to offset any decline and reducing the risk of illness. Older adults who regularly exercise are more resistant to chronic illness (Mazzeo 2001). Clear evidence does exist linking muscle strength (assessed using hand grip strength) and muscle mass to mortality in the elderly (Miller 2002; Rantanen 2000) . These measures can be used as factors in the prediction of long life in this population. There is a strong relationship between functional health status and mortality, as shown by Paffenbarger et al (Paffenbarger 1986) whose study into college alumni demonstrated a significantly lower result in all-cause mortality among those who regularly participated in physical activity. Investigations aimed at optimising and developing the strength and function of frail individuals have been successful when the individuals were trained over a prolonged period, over three months (Brown 1990; Fiatarone 1994; Smith 2006) , indicating that frailty and weakness are reversible and are largely affected by muscle inactivity. This can be potentially overcome by exercise training. Evidence from quality of life and anxiety scores suggest that regular exercise also benefits mental health in the chronically ill (Iversen 2003; Yoshida 1999) . This is vital as this population experiences a greater frequency of negative emotions and depressive symptoms (either arising from the medical condition or as a possible cause in the emergence of the condition) than their healthy counterparts (Baumgartner 1999; Krishnan 2002; Yoshida 1999) . No systematic reviews are yet available on this topic, to quantify the response. With many survivors of critical illness living with reduced function, often beyond a year after their discharge from hospital, it is important to establish whether exercise rehabilitation following critical illness can benefit survivors by improving function and quality of life. This review could help guide rehabilitation practice in the future.
Why it is important to do this review

O B J E C T I V E S
The objective of this systematic review is to assess the effectiveness of exercise rehabilitation programmes, initiated after ICU discharge, on improving functional exercise capacity and quality of life in adult ICU survivors who have been mechanically ventilated for more than 24 hours.
We will compare an exercise intervention to any other intervention or a control or 'usual care' programme. Exercise includes any structured or taught programmes. Respiratory or inspiratory muscle training is excluded due to it being initiated within the ICU environment, for example with weaning from a ventilator, and not as post-discharge rehabilitation as required for this review.
M E T H O D S Criteria for considering studies for this review
Types of studies
We will include randomized controlled trials (RCTs), quasi-RCTs, and controlled clinical trials (CCTs).
Types of participants
We will include all adults (aged 18 years or over) who are mechanically ventilated for 24 hours or more and admitted to an ICU or critical care environment. We will exclude patients that are terminally ill or in palliative care; patients with head injury or involved in trauma,as a large number of subgroups are already addressed in a number of reviews published by the Cochrane Bone, Joint and Muscle Trauma Review Group; and studies examining cardiac surgery patients, as a review has already been published on this patient group (Jolliffe 2001) and this group of patients already have a very specific rehabilitation programme they can access.
Types of interventions
Our experimental intervention will be exercise rehabilitation or training where exercise includes any structured or taught programmes, but not respiratory or inspiratory muscle training (chest physiotherapy). Our comparative intervention will be usual care, a non-exercise intervention, or no intervention.
Types of outcome measures
Primary outcomes 1. Functional exercise capacity (with physical objective assessment and subjective assessment): an individual's maximal ability to perform functional exercise that is beneficial in day-today living, for example, walking, stair climbing, sit-to-stand exercises, and strength.
2. Quality of life, as measured by reliable assessment scales.
Secondary outcomes
1. Withdrawal rates (withdrawal from the intervention or exercise programme) 2. Adherence (ability to adhere to the prescribed protocol within a single exercise session)
3. Mortality 4. Other adverse events
Search methods for identification of studies
The subject search will use a combination of controlled vocabulary and free text terms based on the search strategy for MEDLINE (in Appendix 1).
Electronic searches
We will search Ovid SP MEDLINE (1966 to present) (Appendix 1); Ovid SP EMBASE (1988 to present) (Appendix 2); the current issue of the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library) (Appendix 3); CINAHL via EBSCOhost (Appendix 4).
A search strategy will be developed for use in MEDLINE and revised appropriately for other databases in conjunction with the Cochrane Anaesthesia Review Group. We will not impose any language or publication restrictions.
Searching other resources
We will identify trials by manually searching abstracts of journals including Critical Care, Critical Care Clinics, Physiotherapy, Nursing in Critical Care, and European Society of Intensive Care Medicine. We will check the reference list of included studies and articles. We will attempt to contact relevant trial authors to identify any additional studies.
Data collection and analysis
Selection of studies
Authors will scan the titles and abstracts of reports identified through electronic and manual searches. We will retrieve and evaluate potentially relevant studies, chosen by at least one author, in full-text versions of the reports. Authors will independently select trials that meet the inclusion criteria using a purpose-designed checklist (LG, LS). A third author will act as arbitrator (CT) if the two authors cannot reach a consensus on the studies to be included.
Data extraction and management
Two authors will independently extract data using a standardized checklist (LG, LS). Any disagreement will be resolved by the third author (CT). Data will be collected manually on paper extraction forms and put into intermediate software (Microsoft Excel for Windows), ensuring accurate transference by using double entry, before being entered in to RevMan 5.0. This will allow for any necessary statistical conversions. We will review the data from included studies qualitatively and then, where possible, combine it quantitatively by population, intervention, and outcomes.
Assessment of risk of bias in included studies
Risk of bias will be independently assessed by at least two authors (LG, LS). A third author will arbitrate and resolve any disagreements (CT or TM). As recommended by the Cochrane Handbook (Higgins 2008), the domains to be assessed are: I -sequence generation; II -allocation concealment; III -blinding of participants, personnel, and outcome assessors (for assessment of each main outcome); IV -incomplete outcome data (for assessment of each main outcome); V -selective outcome reporting; VI -other sources of bias. Each will be explicitly judged using 'yes' = low risk of bias, 'no' = high risk of bias, 'unclear' = either lack of information or uncertainty over the potential for bias. For each study, a risk of bias graph and risk of bias summary figure will be constructed from the risk of bias table.
Measures of treatment effect
Where possible, for continuous data the weighted mean difference (WMD), or standardized mean difference (SMD), and 95% confidence interval (CI) will be used for summary statistics (functional exercise capacity, quality of life). Any dichotomous data will be extracted, analysed and reported as relative risk (RR) with 95% CI.
Unit of analysis issues
When different measurement scales are used, attempts will be made to contact lead authors for raw data (for conversion to a standard unit).
Dealing with missing data
Where available, data regarding intention to treat (ITT) will be extracted. If researchers did not perform an ITT analysis but sufficient raw data is available, then an ITT analysis will be conducted prior to data entry to Review Manager. Initially, all data from all studies will be included in the metaanalysis. Secondly, a sensitivity analysis of all studies by excluding those with more than 20% of data missing from the study will be performed.
Assessment of heterogeneity
Heterogeniety will initially be assessed by visual assessment of forest plots from a meta-analysis of studies thought appropriate for pooling. The degree of statistical heterogeneity will be based on the value of the I 2 statistic and, if present, it will be explored through subgroup analysis. We will also undertake quality control checks of data extraction and input, and review the clinical and methodological aspects of the study trials.
Assessment of reporting biases
To assess the level of publication bias, a funnel plot will be used (if we have greater than 10 studies) to make a visual assessment of whether small-study effects may be present in a meta-analysis.
Data synthesis
A fixed-effect Mantel-Haenszel model will be used for dichotomous and continuous data, with the assumption that betweentrial variance is minimal. A random-effects model will be used if the I 2 statistic is greater than 50%. If the studies are sufficiently homogeneous, a meta-analysis will be performed and statistical heterogeneity will be assessed based on an intention-to-treat analysis, where possible.
Subgroup analysis and investigation of heterogeneity
Subgroup analysis is only to be conducted if there are considerable differences in effects, based on: exercise type, intervention duration and frequency, age-related variation, or duration of the critical condition. We do not expect large numbers of studies at this time, in which case subgroup analysis would not be appropriate.
Sensitivity analysis
Sensitivity analysis will be conducted using the Cochrane Handbook definitions (Table 8 .7a) of low, high, or unclear risk of bias to see if the level of risk of bias affects the estimate of effect.
Summary of findings table
We will assess the quality of the total body of evidence associated with our listed outcomes (functional exercise capacity as objective and subjective assessments, quality of life, withdrawal rate, adherence, mortality, and other adverse events) using the principles of the GRADE system (Guyatt 2008). We will construct a 'Summary of findings' (SoF) table using the GRADE software. The GRADE approach appraises the quality of a body of evidence based on the extent to which one can be confident that an estimate of effect or association reflects the object being assessed. The quality of the evidence assessment considers: within study risk of bias (methodologic quality), directness of the evidence, heterogeneity of data, precision of effect estimates, and risk of publication bias. We would like to thank Anna Lee (content editor), Nathan Pace (statistical editor), Tom Overend, Eric B Milbrandt (peer reviewers), Ann Fonfa (Cochrane Consumer Network) for their help and editorial advice during the preparation of this protocol.
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Angus, DC. Understanding the incidence and long-term outcomes of ARDS. In: Gullo, A editor(s Appendix 4. CINAHL (EBSCOhost) search strategy S1 (MH "Therapeutic Exercise+") S2 exercise AND therap* S3 (MH "Exercise+") S4 (MH "Physical Fitness+") S5 (MH "Weight Lifting") S6 (MH "Physical Medicine") S7 (MH "Physical Therapy+") S8 rehabilitation N5 (exercise OR physical) S9 AB (exercise OR physiatrics OR physiatry OR physiotherapy OR mobili*ation) S10 TI activit* S11 movement N5 active S12 movement N5 "whole body" S13 training* OR progressive OR therapy OR intervention S14 exercise N5 S14 S15 aerobic OR endurance OR strength OR resistance OR weight OR fitness OR interval OR circuit S16 training N5 S16 S17 physical therapy OR weight lifting S18 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S15 OR S17 S19 "critical care OR critical illness" S20 (MM "Intensive Care Units") S21 (MH "Atrophy+") S22 (MH "Ventilator Weaning") OR (MH "Ventilators, Mechanical") S23 (MH "Shock, Septic") S24 
